210 related articles for article (PubMed ID: 14603044)
1. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?
Hillman TM; Arriaga MA; Chen DA
Laryngoscope; 2003 Nov; 113(11):1903-7. PubMed ID: 14603044
[TBL] [Abstract][Full Text] [Related]
2. Hearing results of intratympanic steroid treatment of endolymphatic hydrops.
Arriaga MA; Goldman S
Laryngoscope; 1998 Nov; 108(11 Pt 1):1682-5. PubMed ID: 9818826
[TBL] [Abstract][Full Text] [Related]
3. Cochlear implantation in patients with bilateral Ménière's syndrome.
Lustig LR; Yeagle J; Niparko JK; Minor LB
Otol Neurotol; 2003 May; 24(3):397-403. PubMed ID: 12806291
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
5. Oral steroid treatment for hearing improvement in Ménière's disease and endolymphatic hydrops.
Fisher LM; Derebery MJ; Friedman RA
Otol Neurotol; 2012 Dec; 33(9):1685-91. PubMed ID: 23047260
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
7. Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.
Seo YJ; Kim J; Choi JY; Lee WS
Auris Nasus Larynx; 2013 Apr; 40(2):167-72. PubMed ID: 22867525
[TBL] [Abstract][Full Text] [Related]
8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
9. [Visualization of endolymphatic hydrops in 3D-FLAIR MRI after intratympanic Gd-DTPA administration in Meniere's disease patients].
Zhang DG; Shi HL; Fan ZM; Wang GB; Han YC; Li YW; Wang HB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Aug; 48(8):628-33. PubMed ID: 24195817
[TBL] [Abstract][Full Text] [Related]
10. Cochlear microphonics in Ménière's disease.
Ge NN; Shea JJ; Orchik DJ
Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
[TBL] [Abstract][Full Text] [Related]
11. Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière's disease.
Liu Y; Jia H; Shi J; Zheng H; Li Y; Yang J; Wu H
Med Sci Monit; 2015 Mar; 21():701-7. PubMed ID: 25742875
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin treatment: preliminary results in two patients with Menière's disease.
Trine MB; Lynn SG; Facer GW; Kasperbauer JL
J Am Acad Audiol; 1995 May; 6(3):264-70. PubMed ID: 7620206
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
14. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease.
Fukuoka H; Tsukada K; Miyagawa M; Oguchi T; Takumi Y; Sugiura M; Ueda H; Kadoya M; Usami S
Acta Otolaryngol; 2010; 130(1):10-6. PubMed ID: 19363714
[TBL] [Abstract][Full Text] [Related]
15. Clinical observation on acute low-frequency hearing loss without vertigo: the role of cochlear hydrops analysis masking procedure as initial prognostic parameter.
Hong SK; Nam SW; Lee HJ; Koo JW; Kim DH; Kim DR; Kim H
Ear Hear; 2013; 34(2):229-35. PubMed ID: 22976344
[TBL] [Abstract][Full Text] [Related]
16. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease.
Wick CC; Manzoor NF; McKenna C; Semaan MT; Megerian CA
Am J Otolaryngol; 2017; 38(3):285-290. PubMed ID: 28214024
[TBL] [Abstract][Full Text] [Related]
19. Visualization of endolymphatic hydrops in patients with Meniere's disease.
Nakashima T; Naganawa S; Sugiura M; Teranishi M; Sone M; Hayashi H; Nakata S; Katayama N; Ishida IM
Laryngoscope; 2007 Mar; 117(3):415-20. PubMed ID: 17279053
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
